MENU

LUMO

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Lumos Pharma (LUMO) Ownership - Who owns Lumos Pharma?

Lumos Pharma Inc is a biopharmaceutical company that develops treatments for cancer and rare diseases... Show more

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Profile

Industry

N/A

Address

4200 Marathon Boulevard

Phone

+1 512 215-2630

Employees

33

Web

https://www.lumos-pharma.com

Details

Group

Domestic Stock Funds

Category

Biotechnology

Capitalization

37.54M

P/E Ratio

N/A

Total Cash

13.52M

Projected Growth

N/A

Total Debt

172K

Revenue

2.21M

Risk (Beta)

-0.43

Dividend Yield

N/A

Total Cash/Share

1.56

Total Debt/Equity

N/A

Revenue/Share

0.27 USD as % of share price

View a ticker or compare two or three

VS

VS

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for LUMO

A.I. Advisor

published General Information

General Information

a clinical-stage biopharmaceutical company, which engages in the development of therapeutics for the treatment of Pediatric Growth Hormone Deficiency (PGHD)

Industry Biotechnology

Profile

Details

Industry

N/A

Address

4200 Marathon Boulevard

Phone

+1 512 215-2630

Employees

33

Web

https://www.lumos-pharma.com